Skip to main content

Patient notice – Tirzepatide (Mounjaro)

We are aware that a message is circulating on local social media suggesting that Tirzepatide (Mounjaro) will be available for weight loss prescriptions from GPs starting 23rd June. As a result, we have received a high volume of enquiries.

Please note that while the guidance refers to ‘primary care’, this does not mean individual GP practices. We have been explicitly advised not to prescribe this medication.

Find out more about Mounjaro (Tirzepatide) access in Cheshire and Merseyside on the ICB website.

Integrated Care Board (ICB)

NHS Cheshire and Merseyside, the integrated care board (ICB) for the region, is responsible for planning NHS services for the population, which includes the care you receive at your GP practice, local pharmacy, NHS dentist, NHS opticians, or at hospital.

The ICB serve a population of over 2.7m people across:

Working alongside the wider integrated care partnership, ICBs have four key aims:

  • Improve outcomes in population health and healthcare
  • Tackle inequalities in outcomes, experience and access
  • Enhance productivity and value for money
  • Help the NHS support broader social and economic development

To support their vision, local health and care services are working together, as equal partners, to support seamless, person centred care and tackle health inequalities by improving the lives of the poorest fastest.

For more information about Cheshire and Merseyside ICB, please visit www.cheshireandmerseyside.nhs.uk.

Page published: 5 May 2023
Last updated: 11 June 2024